Diagnostic and Prognostic Value of MicroRNA-193b in Patients with Glioma and Its Effect on Tumor Progression

Overview

Journal Oncol Lett

Specialty Oncology

Date 2019 Oct 16

PMID 31611998

Citations 9

Authors

Mingtao Zhu

Wei Zhao

Hui Zhao

Jing Zhang

Affiliations

Soon will be listed here.

Abstract

Emerging evidence has indicated the important roles of microRNAs (miRs) in the pathogenesis of cancer in humans. The present study sought to assess the expression patterns of miR-193b in patients with glioma, and investigated its clinical significance and biological function in this disease. The expression of miR-193b in the serum, tissues and cells of patients with glioma was analyzed using reverse transcription-quantitative PCR. Its diagnostic value was evaluated using the receiver operating characteristic (ROC) curve analysis, and its prognostic value was analyzed using Kaplan-Meier survival and Cox regression analyses. Experiments on glioma cells were conducted to explore the influence of miR-193b on proliferation, migration and invasion. Increased expression of miR-193b was observed in serum, tissues and cells of patients with glioma compared with the corresponding controls (all P<0.05). miR-193b expression was associated with the World Health Organization grading and the Karnofsky Performance Scale of the patients (all P<0.05). The area under the curve of the ROC analysis of miR-193b was 0.903, indicating its high diagnostic accuracy for glioma. High expression of miR-193b was associated with poor overall survival rate in patients (P=0.002). Therefore, miR-193b is a potential independent prognostic factor in glioma. Furthermore, the overexpression of this miR in glioma cells led to increased proliferation, migration and invasion, whereas its inhibition resulted in the opposite effects on these cell behaviors (all P<0.05). Thus, the findings from the present study indicate that the overexpression of miR-193b serves as a useful biomarker for the diagnosis and prediction of prognosis in glioma. The upregulation of miR-193b expression may enhance glioma progression, and may therefore be a potential target for glioma therapy.

Citing Articles

MicroRNA as a potential diagnostic and prognostic biomarker in brain gliomas: a systematic review and meta-analysis.

Hasani F, Masrour M, Jazi K, Ahmadi P, Hosseini S, Lu V Front Neurol. 2024; 15:1357321.

PMID: 38487328 PMC: 10937740. DOI: 10.3389/fneur.2024.1357321.

Circulating serum miR-362-3p and miR-6721-5p as potential biomarkers for classification patients with adult-type diffuse glioma.

Niemira M, Bielska A, Chwialkowska K, Raczkowska J, Skwarska A, Erol A Front Mol Biosci. 2024; 11:1368372.

PMID: 38455766 PMC: 10918470. DOI: 10.3389/fmolb.2024.1368372.

Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets.

Kciuk M, Yahya E, Mohamed M, Abdulsamad M, Allaq A, Gielecinska A Cancers (Basel). 2023; 15(13).

PMID: 37444408 PMC: 10340789. DOI: 10.3390/cancers15133298.

Overexpression of NNMT in Glioma Aggravates Tumor Cell Progression: An Emerging Therapeutic Target.

Sun W, Zou Y, Cai Z, Huang J, Hong X, Liang Q Cancers (Basel). 2022; 14(14).

PMID: 35884600 PMC: 9316405. DOI: 10.3390/cancers14143538.

High miR-3648 expression and low APC2 expression are associated with shorter survival and tumor progression in NSCLC.

Dong Y, Wu B, Wang X, Lu F, Li Q, Zhao Q Histol Histopathol. 2021; 37(4):355-364.

PMID: 34927228 DOI: 10.14670/HH-18-411.

References

Zhong Q, Wang T, Lu P, Zhang R, Zou J, Yuan S . miR-193b promotes cell proliferation by targeting Smad3 in human glioma. J Neurosci Res. 2014; 92(5):619-26. DOI: 10.1002/jnr.23339. View

Gu X, Gong H, Shen L, Gu Q . MicroRNA-129-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting DNMT3A. Am J Transl Res. 2018; 10(9):2834-2847. PMC: 6176228. View

Lu X, Lu J . The significance of detection of serum miR-423-5p and miR-484 for diagnosis of colorectal cancer. Clin Lab. 2015; 61(1-2):187-90. DOI: 10.7754/clin.lab.2014.140625. View

Chan C, Lai K, Ng E, Kiang M, Kwok T, Wang H . Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients. Oncol Lett. 2018; 15(3):3273-3280. PMC: 5778798. DOI: 10.3892/ol.2017.7698. View

Olar A, Aldape K . Using the molecular classification of glioblastoma to inform personalized treatment. J Pathol. 2013; 232(2):165-77. PMC: 4138801. DOI: 10.1002/path.4282. View

Guo F, Luo Y, Mu Y, Qin S, Qi Y, Qiu Y . miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer. Am J Cancer Res. 2016; 6(11):2463-2475. PMC: 5126266. View

Fan Z, Cui H, Xu X, Lin Z, Zhang X, Kang L . MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3. Oncotarget. 2015; 6(28):25266-80. PMC: 4694830. DOI: 10.18632/oncotarget.4457. View

Zhao C, Wang X, Zhang Y, Zhou Y, Yin Q, Yao W . MicroRNA-424 inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting KIF23 and functions as a novel prognostic predictor. Eur Rev Med Pharmacol Sci. 2018; 22(19):6369-6378. DOI: 10.26355/eurrev_201810_16049. View

Guo S, Zeng H, Huang P, Wang S, Xie C, Li S . MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer. Eur Rev Med Pharmacol Sci. 2018; 22(19):6379-6385. DOI: 10.26355/eurrev_201810_16050. View

10.

Harrandah A, Mora R, Chan E . Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Cancer Lett. 2018; 438:126-132. DOI: 10.1016/j.canlet.2018.09.019. View

11.

Xu J, He J, Huang H, Peng R, Xi J . MicroRNA-423-3p promotes glioma growth by targeting PANX2. Oncol Lett. 2018; 16(1):179-188. PMC: 6006452. DOI: 10.3892/ol.2018.8636. View

12.

Wang L, Zhang Y, Zhao L, Liu S, Yu S, Ma Y . MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1. Acta Histochem. 2016; 118(4):323-30. DOI: 10.1016/j.acthis.2016.02.001. View

13.

Wang H, Song X, Huang Q, Xu T, Yun D, Wang Y . LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis. Cancer Epidemiol Biomarkers Prev. 2018; 28(4):760-769. DOI: 10.1158/1055-9965.EPI-18-0638. View

14.

Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View

15.

Li Z, Qian R, Zhang J, Shi X . MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells. Biosci Rep. 2018; 39(3). PMC: 6395304. DOI: 10.1042/BSR20180879. View

16.

Dassow H, Aigner A . MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy. Curr Pharm Des. 2013; 19(7):1242-52. DOI: 10.2174/138161213804805739. View

17.

Chambless L, Kistka H, Parker S, Hassam-Malani L, McGirt M, Thompson R . The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme. J Neurooncol. 2014; 121(2):359-64. DOI: 10.1007/s11060-014-1640-x. View

18.

Stoltz K, Sinyuk M, Hale J, Wu Q, Otvos B, Walker K . Development of a Sox2 reporter system modeling cellular heterogeneity in glioma. Neuro Oncol. 2014; 17(3):361-71. PMC: 4483103. DOI: 10.1093/neuonc/nou320. View

19.

Zhang L, Zhu Y, Cheng H, Zhang J, Zhu Y, Chen H . The Increased Expression of Estrogen-Related Receptor α Correlates with Wnt5a and Poor Prognosis in Patients with Glioma. Mol Cancer Ther. 2018; 18(1):173-184. DOI: 10.1158/1535-7163.MCT-17-0782. View

20.

Yin W, Nie Y, Chen L, Wang Q, Liu S, He X . Deregulation of microRNA-193b affects the proliferation of liver cancer via myeloid cell leukemia-1. Oncol Lett. 2018; 15(3):2781-2788. PMC: 5778835. DOI: 10.3892/ol.2017.7690. View